EPW
TNYA icon

Endeavor Private Wealth’s Tenaya Therapeutics TNYA Stock Holding History

Endeavor Private Wealth’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.43K Buy
+11,400
New +$8.66K ﹤0.01% 216

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Endeavor Private Wealth's TNYA Position: Q2 2026 in Review

Endeavor Private Wealth opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 11,400 shares worth $8.43K. The stake represents ﹤0.01% of the portfolio and ranks #216 among its holdings.

101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Endeavor Private Wealth held 11,400 shares of Tenaya Therapeutics worth $8.43K as of Q2 2026.
  • Tenaya Therapeutics was a new Endeavor Private Wealth position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Endeavor Private Wealth's portfolio in Q2 2026, its #216 holding.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Endeavor Private Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.